Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
Diagnostics (Basel, Switzerland)|May 27, 2026
Evaluating the Diagnostic Accuracy of Point-of-Care CXCL13 Measurements for Lyme NeuroborreliosisLasse Fjordside, Mathilde Ørbæk, Thomas Bryrup, et al.
The Journal of Infectious Diseases|September 21, 2019
Abdominal Adipose Tissue Is Associated With Alterations in Tryptophan-Kynurenine Metabolism and Markers of Systemic Inflammation in People With Human Immunodeficiency VirusMarco Gelpi, Per Magne Ueland, Marius Trøseid, et al.
BMC Infectious Diseases|May 23, 2013
Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case-control studyAndreas Knudsen, Holger Jon Møller, Terese L Katzenstein, et al.
AIDS (London, England)|February 26, 2014
Plasma plasminogen activator inhibitor-1 predicts myocardial infarction in HIV-1-infected individualsAndreas Knudsen, Terese L Katzenstein, Thomas Benfield, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 29, 2008
Coronary and peripheral endothelial function in HIV patients studied with positron emission tomography and flow-mediated dilation: relation to hypercholesterolemiaAnne-Mette Lebech, Ulrik Sloth Kristoffersen, Niels Wiinberg, et al.
Vascular Health and Risk Management|February 1, 2014
Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C--a cross-sectional studyTorsten Roed, Ulrik Sloth Kristoffersen, Andreas Knudsen, et al.
Acta Paediatrica (Oslo, Norway : 1992)|April 5, 2025
Oral Doxycycline Was a Safe and Feasible Treatment in Young Children With NeuroborreliosisJoakim Bloch, Lisbeth Schmidt, Nadja Vissing, et al.
Ticks and Tick-Borne Diseases|November 4, 2022
Exploration of the induced cytokine responses in European Lyme neuroborreliosis: A longitudinal cohort studyRosa Maja Møhring Gynthersen, Mathilde Ørbæk, Helene Mens, et al.
Clinical Biochemistry|June 7, 2020
Soluble urokinase plasminogen activator receptor (suPAR) is lower in disease-free patients but cannot rule out incident disease in patients with suspected cancerLine J H Rasmussen, Martin Schultz, Kasper Iversen, et al.
Neuroimmunomodulation|August 24, 2006
Self-reported fatigue common among optimally treated HIV patients: no correlation with cerebral FDG-PET scanning abnormalitiesAse B Andersen, Ian Law, Sisse R Ostrowski, et al.
Pageof 17